Support group utilization and impact for patients with hidradenitis suppurativa - 19/06/20
Funding sources: Use of REDCap through Penn State is supported by National Institutes of Health/National Center for Advancing Translational Science grants UL1 TR000127 and UL1 TR002014 through the Penn State Clinical & Translational Research Institute, Pennsylvania State University Clinical and Translational Science Award (CTSA). |
|
Conflicts of interest: None disclosed. |
|
IRB approval status: Reviewed and approved by Penn State IRB STUDY00009117. |
|
Presented as a poster at the Symposium on Hidradenitis Suppurativa Advances in Toronto, Canada, October 12-14, 2018. |
Vol 83 - N° 1
P. 216-219 - juillet 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?